Skip to main content
Clinical Trials/NL-OMON36746
NL-OMON36746
Recruiting
Not Applicable

Clinical outcome and cost effectiveness analysis of nutritional rehabilitation on physical functioning and cardiometabolic risk profile in COPD patients with muscle atrophy - NUTRAIN study

Medisch Universitair Ziekenhuis Maastricht0 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
120
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • Clinically stable COPD patients with muscle atrophy eligible for pulmonary rehabilitation. Based on recent studies in COPD and health reference groups, muscle atrophy is defined as a fat\-free mass index (FFMI) under the sex\- and age\-specific 25th percentile FFMI values, assessed by DEXA.
  • Subjects have to be aged over 18, may not get pregnant during the study and have to stop possible intake of current nutritional supplements.Eligible patients will be included after signing informed consent.

Exclusion Criteria

  • \-COPD patients under the age of 18;
  • \-Allergy or intolerance to fish, milk or other product components;
  • \-Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements;
  • \-Not able to stop current supplement use or if total use will be above safe upper limits;
  • \-Participation in any other study involving investigational or marketed products concomitantly or within two weeks prior to entry into the study;
  • \-Pregnancy;
  • \-Life threatening diseases like tuberculosis, carcinoma, AIDS (including HIV\+), acute leukaemia etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials